Top Pharmaceuticals companies in Netherlands by Price to Sales Ratio (P/S)

This ranking features the top 4 Pharmaceuticals companies in Netherlands ranked by Price to Sales Ratio (P/S), averaging a Price to Sales Ratio (P/S) of 9.26, for January 15, 2025.

Netherlands

Pharmaceuticals
Price to Sales Ratio (P/S)
#
Name
Price to Sales Ratio (P/S)
 Reported Date
Stock Price
Change
 Price (30 days) Country
1
ARGX.BR

argenx SE

1

ARGX.BR

32.85

 Jan. 14, 2025 USD 673.61 1.66%

Netherlands
2
IMCD.AS

IMCD N.V.

2

IMCD.AS

1.70

 Jan. 14, 2025 USD 139.49 1.47%

Netherlands
3
RDC.DE

Redcare Pharmacy NV

3

RDC.DE

1.32

 Jan. 14, 2025 USD 121.51 5.06%

Netherlands
4
PHIA.AS

Koninklijke Philips N.V.

4

PHIA.AS

1.17

 Jan. 14, 2025 USD 24.98 -2.69%

Netherlands
Frequently Asked Questions
  • Which Pharmaceuticals company in Netherlands has the highest Price to Sales Ratio (P/S) ?

    The Pharmaceuticals company in Netherlands with the highest Price to Sales Ratio (P/S) is argenx SE (Brussels Stock Exchange: ARGX.BR) at 32.85.

  • Which Pharmaceuticals company in Netherlands has the lowest Price to Sales Ratio (P/S) ?

    The Pharmaceuticals company in Netherlands with the lowest Price to Sales Ratio (P/S) is Koninklijke Philips N.V. (Amsterdam Stock Exchange: PHIA.AS) at 1.17.